Department of Neuroradiology, University of Toronto, Canada.
Department of Neuroradiology, University of Toronto, Canada; Department of Neuroradiology and Head and Neck Imaging, Princess Margaret Cancer Centre, University of Toronto, Canada.
Radiother Oncol. 2021 Dec;165:94-102. doi: 10.1016/j.radonc.2021.10.018. Epub 2021 Oct 27.
To confirm the prognostic value of radiologic extranodal extension (rENE) and its role in clinical-N classification in nasopharyngeal carcinoma (NPC) treated in a western institution.
NPC treated between 2010 and 2017 were included. Pre-treatment MRI were reviewed for unequivocal rENE and its grade: grade-1: tumour invading through any nodal capsule but confined to perinodal fat; grade-2: ≥2 adjacent nodes forming a coalescent nodal mass; grade-3: tumour extending beyond perinodal fat to invade/encase adjacent structures. Overall survival (OS) and disease-free survival (DFS) were compared between rENE-positive (rENE+) and rENE-negative (rENE-) patients. Multivariable analysis (MVA) confirmed the prognostic importance of rENE and its grade. Staging schemas including rENE in N-classification were proposed and their performance evaluated.
A total of 274 patients were eligible (43 cN0; 231 cN-positive). rENE was identified in 83/231 (36%) cN-positive, including grade 1/2/3 rENE in 14/58/11 cases. Compared to rENE-, rENE+ patients had a lower OS (68% vs 89%, p < 0.001) and DFS (58% vs 80%, p < 0.001). MVA confirmed the prognostic importance of grade-2 [HR: OS: 2.85 (p = 0.005); DFS: 2.89 (p < 0.001)] and grade-3 rENE [HR: OS 5.28 (p = 0.004); DFS 3.86 (p = 0.005)], with a trend for grade-1 vs rENE- [HR: OS 2.63 (p = 0.13); DFS 1.49 (p = 0.520)]. We evaluated classifying any rENE as cN3 (Proposal-I) or any grade-2/grade-3 rENE as cN3 (Proposal-II). The stage schema with Proposal-I cN-classification ranked the highest in the performance evaluation.
rENE is an important prognostic factor in this western NPC cohort. We propose classifying any unequivocal rENE as cN3.
在西方医疗机构治疗的鼻咽癌(NPC)中,确认放射学结外侵犯(rENE)的预后价值及其在临床 N 分类中的作用。
纳入 2010 年至 2017 年间治疗的 NPC 患者。对治疗前 MRI 进行评估,以明确 rENE 及其分级:1 级:肿瘤穿过任何淋巴结包膜,但局限于包膜内脂肪;2 级:≥2 个相邻淋巴结形成融合性淋巴结团块;3 级:肿瘤侵犯包膜外脂肪,侵犯/包裹相邻结构。比较 rENE 阳性(rENE+)和 rENE 阴性(rENE-)患者的总生存(OS)和无病生存(DFS)。多变量分析(MVA)确认了 rENE 及其分级的预后重要性。提出了包括 rENE 在 N 分类中的分期方案,并评估了其性能。
共有 274 名患者符合条件(43 例 cN0;231 例 cN+)。在 231 例 cN+中,有 83 例(36%)存在 rENE,其中 14 例、58 例和 11 例分别为 1 级/2 级/3 级 rENE。与 rENE-相比,rENE+患者的 OS(68% vs 89%,p<0.001)和 DFS(58% vs 80%,p<0.001)较低。MVA 证实了 2 级 rENE [HR:OS:2.85(p=0.005);DFS:2.89(p<0.001)]和 3 级 rENE [HR:OS 5.28(p=0.004);DFS 3.86(p=0.005)]的预后重要性,1 级 rENE 也有趋势[HR:OS 2.63(p=0.13);DFS 1.49(p=0.520)]。我们评估了将任何 rENE 分类为 cN3(方案 I)或任何 2 级/3 级 rENE 分类为 cN3(方案 II)。在性能评估中,方案 I 的 cN 分类表现最佳。
rENE 是西方 NPC 队列中一个重要的预后因素。我们建议将任何明确的 rENE 分类为 cN3。